
Platform unlocks health data
- TRANSFORMERS.health
- August 27, 2024
- FRESH LEMONMINT
- data
- 0 Comments
Lemonmint supports MDClone in bringing their Healthcare Data Platform, ADAMS, to Germany. This advancement comes at a pivotal time as Germany’s healthcare system undergoes significant changes. With the implementation of the Health Data Usage Act (HDUA), German hospitals are now equipped to collect and analyze more comprehensive data than ever before. ADAMS empowers authorized researchers and healthcare professionals to unlock insights from multi-source data sets while maintaining strict privacy standards through synthetic data capabilities.
The ADAMS platform empowers hospitals to convert raw data into actionable strategies that enhance patient care and operational efficiency.
Already in use by some of the world’s most prestigious healthcare institutions – including University Hospital Basel, McGill University Health Centre, and the University of Chicago – ADAMS has won numerous awards, including “Best Healthcare Big Data Platform” for four consecutive years.
ADAMS integrates seamlessly with Electronic Health Record (EHR) vendors such as Cerner and Epic, ensuring comprehensive data interoperability. This allows the platform to serve as a robust data lake that can unify and analyze information from a wide variety of sources crucial for tracking clinical activity.

MDClone’s ADAMS platform is helping some of the world’s leading hospitals, including Sheba Medical Center, implement actionable data strategies by empowering clinicians to derive insights from comprehensive data sets.
Supporting Data-Driven Hospital Management and Cutting-Edge Research
ADAMS will assist German hospitals to transform into fully data-driven enterprises by giving them access to leading edge data exploration capabilities. At Veterans Health Administration (USA), the platform supports collaborative research, predicting Alzheimer’s, suicide prevention, and heart failure. Sheba Medical Center in Israel uses ADAMS for scaled innovation, enhancing GI lab throughput, antibiotic management, and monitoring head trauma. In all these scenarios, ADAMS utilizes synthesized in-house health data to ensure highest privacy standards.
As Germany’s hospital sector undergoes restructuring, the research capabilities of ADAMS can offer critical insights to address financial and performance-based challenges. By replicating the successes seen in other leading institutions, German hospitals can drive both clinical and operational excellence in the country’s evolving healthcare environment.
For further information visit www.mdclone.com